Method of diagnosing and/or prognosticating HIV infection in a subject comprising
the steps of: (a) performing in vitro a measurement of the level of a marker in
the form of (i) urokinase plasminogen activator receptor (uPAR), (ii) soluble urokinase
plasminogen activator receptor (suPAR), (iii) urokinase-type plasminogen activator
(uPA), (iv) one or more degradation products of (i), (ii), or (iii), and/or (v)
an mRNA for (i), (ii) or (iii), in a biological fluid sample from a subject, and
(b) using the measurement value obtained to evaluate the state of the subject.
